SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its patent ...

SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...

Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...

SEATTLE, Dec. 7, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for ...

The accurate detection of bloodstream infections is central to effective patient management, yet false‐positive results from blood culture contamination continue to impose significant clinical and ...

FRANKLIN LAKES, N.J., Oct. 18, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today ...

Blood Cultures are the gold standard test for Sepsis diagnosis and an essential first step in infectious organism identification. Improving its quality is critical to the outcomes for a patient with ...

Blood culture is the most widely used diagnostic tool for the detection of bacteremia and fungemia. It is the most important way to diagnose the etiology of bloodstream infections and has major ...

Recently published University of Arkansas study examined the patient-specific risk factors and clinical outcomes associated with contaminated blood cultures for patients with suspected bloodstream ...

SAN DIEGO--(BUSINESS WIRE)--Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin ® blood culture collection sets, announced today that the United States Patent Office allowed its patent ...